Peptide Vials (BPC-157, 10 mg each): 8 weeks 3 vials (25.2 mg used) 12 weeks 5 vials (42 mg used) 16 weeks 6 vials (58.8 mg used) Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
BPC-157 supports recovery but does not override continued tissue damage from ongoing activity
While some peptides focus solely on collagen stimulation, GHK-Cu takes a holistic approach enhancing elasticity , reducing inflammation , and protecting against oxidative damage
As these compounds are supplied for laboratory research only, we do not provide dosing or administration protocols
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
Built for What's inside What it does How it's verified If this sounds like you What Core 157 delivers Why Core 157 stands apart The range Tested
